Latest Financial Milestones News

Aurelia Metals has locked in a A$150 million senior secured financing package, strengthening its balance sheet and unlocking restricted cash to support its copper production growth targets.

Cann Group Limited has raised $750,000 through a convertible note agreement with Obsidian Global, aiming to strengthen its working capital and move towards EBITDA positivity.

Capstone Copper has reported record-breaking copper production and adjusted EBITDA for Q4 and full-year 2025, while progressing key expansion projects and maintaining stable guidance for 2026.

Life360 has delivered a landmark 2025 with record user growth, revenue, and profitability, driven by its expanding subscription base and new advertising ventures. The company’s transition to an AI-first platform and strategic acquisitions set the stage for ambitious growth in 2026.

Wrkr Ltd reports a 43% revenue increase to nearly $7 million in H1 FY2026 but also a 75% rise in net loss, while completing a $15 million capital raise and acquiring payroll compliance firm PaidRight.

Podium Minerals has disclosed the initial securities interests of its newly appointed directors, highlighting a significant allocation of performance rights to Gary Humphries while Neal Froneman holds none.

Cann Group Limited has reported its first-ever free cash flow positive quarter, following a significant debt restructuring and a $9 million capital raise. Despite a softer quarterly revenue, the company is advancing new product launches and export partnerships, positioning itself for growth.

Arcadia Minerals Limited has voluntarily suspended trading of its shares pending a significant announcement about a capital raising and earn-in deal at the Swanson Tantalum mine.

Neurizon Therapeutics has locked in a $6 million cash rebate from the Australian Government’s R&D Tax Incentive, underpinning its upcoming HEALEY ALS Platform Trial with first patient dosing slated for early 2026.

CurveBeam AI reported steady device orders alongside a $4 million milestone payment from its China commercialisation deal, while progressing FDA clearance and robotic surgery system validation.

Cleo Diagnostics has broadened its U.S. market opportunity to around 2 million women annually and is on track to complete its pivotal clinical trial early this year, supported by a $5 million capital raise and regulatory progress.

Beacon Minerals has successfully completed the first blast at its Lady Ida Iguana open pit, marking a pivotal step towards gold production expected to commence in February 2026.